» Articles » PMID: 23807651

Multi-copper Oxidases and Human Iron Metabolism

Overview
Journal Nutrients
Date 2013 Jun 29
PMID 23807651
Citations 73
Authors
Affiliations
Soon will be listed here.
Abstract

Multi-copper oxidases (MCOs) are a small group of enzymes that oxidize their substrate with the concomitant reduction of dioxygen to two water molecules. Generally, multi-copper oxidases are promiscuous with regards to their reducing substrates and are capable of performing various functions in different species. To date, three multi-copper oxidases have been detected in humans--ceruloplasmin, hephaestin and zyklopen. Each of these enzymes has a high specificity towards iron with the resulting ferroxidase activity being associated with ferroportin, the only known iron exporter protein in humans. Ferroportin exports iron as Fe(2+), but transferrin, the major iron transporter protein of blood, can bind only Fe(3+) effectively. Iron oxidation in enterocytes is mediated mainly by hephaestin thus allowing dietary iron to enter the bloodstream. Zyklopen is involved in iron efflux from placental trophoblasts during iron transfer from mother to fetus. Release of iron from the liver relies on ferroportin and the ferroxidase activity of ceruloplasmin which is found in blood in a soluble form. Ceruloplasmin, hephaestin and zyklopen show distinctive expression patterns and have unique mechanisms for regulating their expression. These features of human multi-copper ferroxidases can serve as a basis for the precise control of iron efflux in different tissues. In this manuscript, we review the biochemical and biological properties of the three human MCOs and discuss their potential roles in human iron homeostasis.

Citing Articles

The Ferroxidase-Permease System for Transport of Iron Across Membranes: From Yeast to Humans.

Amadei M, Polticelli F, Musci G, Bonaccorsi di Patti M Int J Mol Sci. 2025; 26(3).

PMID: 39940646 PMC: 11817551. DOI: 10.3390/ijms26030875.


Copper metabolism in osteoarthritis and its relation to oxidative stress and ferroptosis in chondrocytes.

Yu Q, Xiao Y, Guan M, Zhang X, Yu J, Han M Front Mol Biosci. 2024; 11:1472492.

PMID: 39329090 PMC: 11425083. DOI: 10.3389/fmolb.2024.1472492.


Comparison of Molecular Potential for Iron Transfer across the Placenta in Domestic Pigs with Varied Litter Sizes and Wild Boars.

Kopec Z, Starzynski R, Lenartowicz M, Grzesiak M, Opiela J, Smorag Z Int J Mol Sci. 2024; 25(17).

PMID: 39273585 PMC: 11395084. DOI: 10.3390/ijms25179638.


Vitamin C-Dependent Uptake of Non-Heme Iron by Enterocytes, Its Impact on Erythropoiesis and Redox Capacity of Human Erythrocytes.

Pan X, Koberle M, Ghashghaeinia M Antioxidants (Basel). 2024; 13(8).

PMID: 39199214 PMC: 11352176. DOI: 10.3390/antiox13080968.


The Effects of Fisetin and Curcumin on Oxidative Damage Caused by Transition Metals in Neurodegenerative Diseases.

Bjorklund G, Oliinyk P, Khavrona O, Lozynska I, Lysiuk R, Darmohray R Mol Neurobiol. 2024; 62(1):1225-1246.

PMID: 38970766 DOI: 10.1007/s12035-024-04321-2.


References
1.
Nittis T, Gitlin J . Role of copper in the proteosome-mediated degradation of the multicopper oxidase hephaestin. J Biol Chem. 2004; 279(24):25696-702. DOI: 10.1074/jbc.M401151200. View

2.
Nakamura K, Go N . Function and molecular evolution of multicopper blue proteins. Cell Mol Life Sci. 2005; 62(18):2050-66. PMC: 11139126. DOI: 10.1007/s00018-004-5076-x. View

3.
Danielson P . The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans. Curr Drug Metab. 2002; 3(6):561-97. DOI: 10.2174/1389200023337054. View

4.
Sakurai T, Kataoka K . Structure and function of type I copper in multicopper oxidases. Cell Mol Life Sci. 2007; 64(19-20):2642-56. PMC: 11136192. DOI: 10.1007/s00018-007-7183-y. View

5.
Gunshin H, Fujiwara Y, Custodio A, Direnzo C, Robine S, Andrews N . Slc11a2 is required for intestinal iron absorption and erythropoiesis but dispensable in placenta and liver. J Clin Invest. 2005; 115(5):1258-66. PMC: 1077176. DOI: 10.1172/JCI24356. View